Rick Bartram
Förmögenhet: 3 M $ per 2026-06-30
Förmögenhet: 3 M $ per 2026-06-30
Richard B. Bartram worked at PricewaterhouseCoopers LLP from 2005 to 2013 as an Assurance Manager.
From 2013 to 2022, worked at Esperion Therapeutics, Inc., serving as Vice President-Finance from 2015 to 2018.
From 2022 to 2026, worked at MBX Biosciences, Inc. as Chief Financial Officer.
Attended Michigan State University for undergraduate and graduate degrees.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-10 | 48 757 ( 0,1 % ) | 3 M $ | 2026-06-30 |
| Företag | Position | Slut |
|---|---|---|
| MBX BIOSCIENCES, INC. | Finansdirektör/CFO | 2026-05-15 |
| ESPERION THERAPEUTICS, INC. | Finansdirektör/CFO | 2022-04-08 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Företagsledare/Principal | 2013-02-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Michigan State University
Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MBX Biosciences, Inc.
MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån